课题基金 / 基金详情

Control of placental infection by decidual NK cell secreted granulysin

Control of placental infection by decidual NK cell secreted granulysin
蜕膜NK细胞分泌颗粒溶素控制胎盘感染
批准号:
9092639
负责人:
Judy Lieberman
金额:
$27.68万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-03-04 至 2018-02-28

项目摘要

项目成果

Judy Lieberman的其他基金

相似基金

相关文献

中文摘要
翻译
 描述(由申请人提供):在妊娠期间,母体免疫细胞需要建立胎儿和胎盘组织的免疫耐受性,但也要保护免受感染。蜕膜NK细胞(dNK)是母胎界面上最大的母体免疫细胞群,其中母体和胎儿组织相互作用。这项提议将探索一种新的令人兴奋的机制,通过这种机制,dNK杀死感染胎儿滋养层细胞的细菌,但保留胎儿细胞。人dNK高度表达颗粒溶素,颗粒溶素是一种优先破坏微生物膜的抗微生物肽,但对哺乳动物膜的活性较低。颗粒溶素作为无活性的15 kDa前肽产生,其在杀伤细胞细胞毒性颗粒中加工成9 kDa膜溶解肽。我们的初步数据表明,dNK细胞有两个细胞内池的颗粒溶解素-一个池包含活性和非活性形式的颗粒溶解素的细胞毒性颗粒与穿孔素和颗粒酶,而另一个池只包含非活性的颗粒溶解素前体。初步数据表明,dNK组成型分泌高水平的颗粒溶解素,而没有其他细胞溶解分子。文化 来自dNK细胞的上清液而不是外周血NK细胞(pNK)的上清液杀死细胞外L.单核细胞增多症以及L.在胎儿滋养层细胞系内的单核细胞增多症而不杀死滋养层。基于这些初步数据,我们假设颗粒溶素分泌杀死胎儿细胞中的细胞内病原体而不伤害这些细胞。为了研究这个假设, 我们建议证实我们的初步数据,即细胞内微生物被颗粒溶素的dNK分泌杀死,而与穿孔素和颗粒酶无关;确定细菌或细菌产物或炎性细胞因子是否上调颗粒溶素的表达和分泌;并了解滋养层如何抵抗杀死。我们还将确定颗粒溶素分泌是组成性的还是受调节的,并研究dNK对感染的胎儿绒毛外滋养层细胞(EVT,蜕膜中最具侵袭性的胎儿细胞)的反应是否与母体蜕膜基质细胞(DSC)不同。我们将使用成像来确定dNK细胞是否与这些感染的细胞形成免疫突触,突触的类型是否不同,以及是否会触发细胞毒性颗粒的释放。使用的模型将是3种导致妊娠期并发症的病原体- L。单核细胞增多症、B族链球菌(GBS)和刚地弓形虫。
英文摘要
 DESCRIPTION (provided by applicant): During pregnancy maternal immune cells need to establish immune tolerance of fetal and placental tissues, but also protect against infection. Decidual NK cells (dNK) are the largest maternal immune cell population at the maternal-fetal interface, where maternal and fetal tissues interact. This proposal will explore a novel and exciting mechanism by which dNK kill bacteria that infect fetal trophoblasts, but spare the fetal cells. Human dNKs highly express granulysin, an antimicrobial peptide that preferentially disrupts the membranes of microbes, but is less active against mammalian membranes. Granulysin is produced as an inactive 15 kDa pro-peptide that is processed in killer cell cytotoxic granules to a 9 kDa membranolytic peptide. Our preliminary data suggest that dNK cells have two intracellular pools of granulysin - one pool contains both the active and inactive forms of granulysin in cytotoxic granules together with perforin and granzymes, while the other pool contains only the inactive granulysin precursor. Preliminary data demonstrate that dNK constitutively secrete high levels of granulysin without the other cytolytic molecules. The culture supernatants from dNKs, but not peripheral blood NK cells (pNK), kill extracellular L. monocytogenes as well as L. monocytogenes within fetal trophoblast cell lines without killing the trophoblast. Based on these preliminary data, we hypothesize that granulysin secretion kills intracellular pathogens in fetal cells without harming those cells. To investigate this hypothesis, we propose to confirm our preliminary data showing that intracellular microbes are killed by dNK secretion of granulysin, independently of perforin and granzymes; determine whether bacteria or bacterial products or inflammatory cytokines upregulate granulysin expression and secretion; and understand how the trophoblast resists killing. We will also define whether granulysin secretion is constitutive or regulated and investigate whether dNKs respond differently to infected fetal extravillous trophoblasts (EVT, the most invasive fetal cells in the decidua) than t maternal decidual stromal cells (DSC). We will use imaging to determine whether dNK cells form an immune synapse with these infected cells, whether the type of synapse differs and whether the encounter triggers cytotoxic granule release. The models used will be 3 pathogens that cause complications during pregnancy - L. monocytogenes, Group B Streptococci (GBS) and Toxoplasma gondii.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Tumor-targeted disruption of mismatch repair in microsatellite stable colorectal cancer
  • 批准号:
    10578049
  • 项目类别:
  • 资助金额:
    $24.82万
  • 财政年份:
    2022
  • 负责人:
    Judy Lieberman
  • 依托单位:
Mechanistic elucidation of inflammasome assembly and regulation. Supplement: Testing drugs that curtail inflammasome activation to suppress SARS-CoV-2 pathogenesis
  • 批准号:
    10159600
  • 项目类别:
  • 资助金额:
    $26.5万
  • 财政年份:
    2020
  • 负责人:
    Judy Lieberman
  • 依托单位:
Gasdermin E and pyroptosis in cancer
  • 批准号:
    10375415
  • 项目类别:
  • 资助金额:
    $49.4万
  • 财政年份:
    2020
  • 负责人:
    Judy Lieberman
  • 依托单位:
Endogenous ligand of the NK activating receptor NKp46
  • 批准号:
    10116279
  • 项目类别:
  • 资助金额:
    $22.13万
  • 财政年份:
    2020
  • 负责人:
    Judy Lieberman
  • 依托单位:
海外基金